Movement disorders in children and adolescents (Q35077736)

6 August 2017

1 reference

title

Movement disorders in children and adolescents (English)

1 reference

6 August 2017

1 reference

William M McMahon

1 reference

6 August 2017

Francis M Filloux

series ordinal

1 reference

6 August 2017

James C Ashworth

series ordinal

1 reference

6 August 2017

Jenise Jensen

series ordinal

1 reference

6 August 2017

language of work or name

1 reference

1 November 2002

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

1101-24, vii-viii

1 reference

Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

An epidemiologic study of Gilles de la Tourette's syndrome in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Adult tics in Gilles de la Tourette's syndrome: description and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Course of tic severity in Tourette syndrome: the first two decades

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

The temporal dynamics of tics in Gilles de la Tourette syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

1 reference

7 January 2021

Significant linkage for Tourette syndrome in a large French Canadian family

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Pathogenesis of Tourette's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tourette's syndrome: when habit-forming systems form habits of their own?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Regional brain and ventricular volumes in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Disproportionate increases of white matter in right frontal lobe in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

The functional neuroanatomy of Tourette's syndrome: an FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Brain Perfusion Abnormalities in Gilles de la Tourette's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

A functional magnetic resonance imaging study of tic suppression in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

High presynaptic dopaminergic activity in children with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

123Ibeta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Corpus callosum measurements in girls with Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Subcortical volumes in girls with tourette syndrome: support for a gender effect

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Anatomical MRI of the developing human brain: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Sexual dimorphism of the developing human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

A quantitative MRI study of the corpus callosum in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Variability of human brain structure size: ages 4-20 years

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Brain development, gender and IQ in children. A volumetric imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tourette's disease: relief of symptoms with R1625

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Treatment of Gilles de la Tourette's Syndrome with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Fluphenazine and multifocal tic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

The trial use of clozapine for abnormal involuntary movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Rapid onset of therapeutic effect of risperidone versus haloperidol in a double-blind randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tics in Tourette syndrome: new treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Restricted unilateral Sydenham's chorea: reversible contralateral striatal hypermetabolism demonstrated on single photon emission computed tomographic scanning

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Sydenham’s Chorea Clinical and Therapeutic Update

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Sydenham chorea: clinical, EEG, MRI and SPECT findings in the early stage of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Sydenham's chorea and psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

The psychiatric symptoms of rheumatic fever.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Are all recurrences of "pure" Sydenham chorea true recurrences of acute rheumatic fever?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Persistent rheumatic chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Anti-Nuclear Antibodies in Sydenham’s Chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

The diagnosis of rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Acute rheumatic fever: changing manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

The resurgence of acute rheumatic fever in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Persistence of acute rheumatic fever in the intermountain area of the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Resurgence of acute rheumatic fever in the intermountain area of the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Antistreptolysin O and Anti-Deoxyribonuclease B Titers: Normal Values for Children Ages 2 to 12 in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Detection and significance of subclinical mitral regurgitation by colour Doppler techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: long term follow up of patients with subclinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Occurrence of valvar heart disease in acute rheumatic fever without evident carditis: colour-flow Doppler identification

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Can subclinical valvitis detected by echocardiography be accepted as evidence of carditis in the diagnosis of acute rheumatic fever?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Doppler echocardiography distinguishes between physiologic and pathologic “silent” mitral regurgitation in patients with rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Hemichorea in systemic lupus erythematosus: significance of MRI findings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Neurological aspects of antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Chorea in primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Chorea and lupus anticoagulant: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Molecular mimicry as a mechanism for virus-induced autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Anti-neuronal antibody in Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

IgG subclass, variable H-chain subgroup, and light chain-type composition of antineuronal antibody in Huntington's Disease and Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Antibodies against human putamen in children with Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Autoimmune mechanisms in movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Sydenham's chorea: MRI and proton spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Sydenham Chorea: magnetic resonance imaging reveals permanent basal ganglia injury

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

SPECT and MRI findings in Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

High-signal basal ganglia on T1-weighted images in a patient with Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Sydenham's chorea: a case showing reversible striatal abnormalities on CT and MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Sydenham's chorea: magnetic resonance imaging of the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Volumetric MRI changes in basal ganglia of children with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Reversible striatal hypermetabolism in a case of Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Serial brain SPECT images in a case of Sydenham chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Increased striatal glucose consumption in Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Rheumatic fever recurrences: controlled study of 3-week versus 4-week benzathine penicillin prevention programs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

On defining Sydenham's chorea: where do we draw the line?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Genetics of childhood disorders: XXXIV. Autoimmune disorders, part 7: D8/17 reactivity as an immunological marker of susceptibility to neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

A flow cytometric assay for D8/17 B cell marker in patients with Tourette's syndrome and obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tourette's syndrome and mycoplasma pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Treatment with atypical antipsychotics: new indications and new populations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Adolescents on neuroleptic medication: is this population at risk for tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Case Series: Spectrum of Neuroleptic-Induced Movement Disorders and Extrapyramidal Side Effects in Childhood-Onset Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Risks of neuroleptic drugs in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Tardive dyskinesia in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

Risperidone and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900015-4

7 January 2021

10.1016/S0733-8619(02)00015-4

Identifiers

DOI

1 reference

6 August 2017

1 reference